- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
P
PRCT
Procept Biorobotics Corp
27.27
0.51+1.91%After Hours: 27.90 +0.63 +2.31%19:43 02/20 EST
OPEN/PREV CLOSE26.61/26.76
TODAY RANGE26.23-27.38
VOL1.76M
MARKET CAP1.52B
52 WEEK RANGE26.23-70.80
AVG VOL (3M)1.26M
% TURNOVER3.15%
TURNOVER--
P/E (TTM)-17.7320
% RANGE4.20%
EPS(TTM)-1.5379
P/E(FORWARD)-18.0407
P/B4.007
BVPS6.81
DIVIDEND--
P/S6.65
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.46B
SHARES OUTSTANDING55.88M
NEXT EARNINGS02/23-02/27
FREE FLOAT53.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Wall Street Analysts Are Neutral on Top Healthcare Picks
Reuters·02/04 21:03
Procept Biorobotics präsentiert sich auf bedeutenden Gesundheitskonferenzen
TipRanks·01/27 13:16
BTIG Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)
NASDAQ·01/07 13:41
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
Seeking Alpha·12/24/2025 13:30
Where To Invest In 2026: Top 5 Secular Growth Trends
NASDAQ·12/22/2025 15:46
Interesting PRCT Put And Call Options For February 2026
Dow Jones·12/18/2025 16:01
PROCEPT BioRobotics Price Target Cut to $47.00/Share From $50.00 by Truist Securities
Dow Jones·12/18/2025 16:01
PROCEPT BioRobotics Is Maintained at Buy by Truist Securities
Benzinga·12/18/2025 15:50
Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $47
TipRanks·12/18/2025 14:15
Procept BioRobotics price target lowered to $47 from $50 at Truist
Dow Jones·12/12/2025 16:22
PROCEPT BioRobotics Price Target Announced at $62.00/Share by UBS
Benzinga·12/12/2025 16:13
UBS Initiates Coverage On PROCEPT BioRobotics with Buy Rating, Announces Price Target of $62
TipRanks·12/12/2025 09:56
Promising Growth and Investment Opportunity for PROCEPT BioRobotics: Analyst Buy Rating
Same Industry
Name/Symbol
Change%
Price